High-Level Medical Diagnostic Services Go Global: Belt and Road Remote Imaging Diagnosis Center Signing Ceremony Successfully Held

VCBeat (WeChat ID: vcbeat) has learned that on December 21, China Merchants Health, Huashan Hospital Affiliated to Fudan University, and Yizhan Medical Group officially held the signing ceremony for their collaboration on the Belt and Road Remote Imaging Diagnosis Center in Shenzhen.

Signing Ceremony (from left to right: Ni Meng, Founder and CEO of Yizhan Medical Group,

Ma Xin, Vice President of Huashan Hospital Affiliated to Fudan University; Zhang Lin, Deputy General Manager of China Merchants Shekou)

The establishment of this tripartite remote imaging diagnosis center, under the framework of the Belt and Road Initiative (BRI), represents a significant step in implementing national initiatives. The three parties are actively exploring a model wherein Huashan Hospital serves as the hub for exporting diagnostic medical expertise, leveraging Wingtech Smart Imaging’s cloud-based diagnostic network and AI-enabled open platform for auxiliary diagnosis. Anchored by China Merchants Group’s 46 overseas ports across 18 countries, high-quality imaging diagnostic services will be extended to regions along these port corridors, thereby delivering advanced healthcare capabilities.

Group Photo of Guests at the Signing CeremonySigning Ceremony (from left to right: Yue Liang, Deputy General Manager of Investment and Asset Management Department, China Merchants Health; Luo Bangqiang, Managing Director, China Merchants Lippo; Chen Songyin, Deputy General Manager, China Merchants Health; Ni Meng, Founder and CEO, Yizhan Medical Group; Ma Xin, Vice President, Huashan Hospital Affiliated to Fudan University; Zhang Lin, Deputy General Manager, China Merchants Shekou; Wang Huiying, Director of the Medical Affairs Department, Huashan Hospital Affiliated to Fudan University; Gao Yunlong, Co-founder and CMO, Yizhan Medical Group; Jia Bo, Section Chief, Huashan Hospital Affiliated to Fudan University; Wen Yanhong, General Manager of Medical and Elderly Care Management Department, China Merchants Health; Zhou Jianzhong, Deputy General Manager of Medical and Elderly Care Management Department, China Merchants Health)

The Center not only provides high-level medical security for Chinese personnel overseas and delivers advanced technological medical services to countries along the Belt and Road Initiative, but the integration of AI products has also emerged as a new highlight in the implementation of the Belt and Road strategy.

As Professor Teng Bingsheng of Strategy at Cheung Kong Graduate School of Business stated, “In the era of artificial intelligence, China will once again achieve overtaking on a bend. The model through which China seized opportunities during the internet age to become a global internet giant is likely to be replicated in the field of AI, enabling it to take the lead globally once more. China boasts a highly complete supporting industry ecosystem and maintains extensive exchanges with U.S. counterparts in terms of talent. In recent years, the Chinese government has attached great importance to the significance of AI for the future economy and has actively provided comprehensive support. Benefiting from the synergy among hardware, software, data, and algorithms, China is poised to make significant strides in this field.” China’s medical technology is advancing rapidly; the continuous R&D and application of AI products will generate new productive forces, serving the world along the Belt and Road Initiative.

Amid economic transformation, the restructuring of the global order, and China’s economy entering a “new normal,” the emergence of a new business civilization is an inevitable path to ensuring the sustainable development of commerce in the future. Distinct from traditional business models, this new business civilization is inclusive and committed to pursuing shared growth.

As China’s largest state-owned enterprise, China Merchants Group has not only generated substantial economic value but also continuously created social value, setting an exemplary standard for corporate responsibility. Meanwhile, Yizhan Medical Group, a representative enterprise in innovation and entrepreneurship, demonstrates the commitment of leading innovative companies under the framework of the new business civilization.

In Ningxia, a demonstration zone for internet healthcare reform that is gaining momentum across China, the Yizhan Remote Imaging Diagnosis Center at Yinchuan First People’s Hospital has been successfully operating for over a year. It has provided high-level diagnostic services to more than 70,000 patients in the autonomous region and received visits and affirmation from Premier Li Keqiang and Vice Premier Sun Chunlan. Ma Xiaofei, Director of the Yinchuan Municipal Health and Family Planning Commission, stated that the primary reason for partnering with Yizhan Medical Group was the strong alignment between Yizhan’s service-oriented business philosophy and Yinchuan’s “Internet Plus Healthcare” system. The construction process adhered to the principle of achieving multi-party win-win outcomes, placing equal importance on social value and economic value. On one hand, it enables residents in northwest China, particularly those at the grassroots level, to access diagnostic capabilities equivalent to those of Grade A tertiary hospitals without incurring additional costs. On the other hand, it provides radiologists at higher-level hospitals with supplementary income. Meanwhile, it facilitates the implementation of the national tiered diagnosis and treatment policy and helps alleviate the uneven distribution of medical resources.

Implementing the Belt and Road Initiative has also provided a global development stage for many high-tech enterprises like Wingtech. Leveraging this platform, numerous companies have achieved counter-trend growth amidst the capital winter.

According to a report by VCBeat and VBInsight, a comparison of the Top 100 medical technology and healthcare service companies, represented by Yizhan, between 2017 and 2018 shows that the total valuation of companies on the 2018 list reached RMB 424.466 billion, marking a significant 32.2% increase from the 2017 Top 100 list. The combined valuation of the top 10 companies exceeded RMB 200 billion, approaching the total valuation of the entire Top 100 in 2016. Over just a few years, Yizhan Medical Group has achieved substantial growth in both valuation and revenue by continuously improving its ecosystem and advancing the development and implementation of AI products, thereby emerging as a unicorn company.

As Ni Meng, Founder and CEO of Yizhan, stated, the company’s original aspiration is to ensure that everyone has access to high-quality medical imaging diagnostics. In this era of rapid technological advancement, entities such as China Merchants Group, Huashan Hospital, Yizhan, and countless other Chinese enterprises are driving industry development through their innovation, capabilities, and vision. They are fostering the integration and progress of business civilization and impacting every individual’s life.

China Merchants Health: A subsidiary of China Merchants Group (CMG). CMG is a key state-owned enterprise directly under the administration of the central government, with its headquarters in Hong Kong. It is also recognized as one of the four major Chinese-funded enterprises in Hong Kong. By the end of 2017, the group’s total assets reached RMB 7.3 trillion, representing a year-on-year increase of 7.8%, ranking first among central state-owned enterprises in terms of scale. China Merchants Group became one of the eight central state-owned enterprises that have received an “A” rating in the operational performance assessments conducted by the State-owned Assets Supervision and Administration Commission (SASAC) of the State Council for 14 consecutive years, and has been designated as an “Enterprise with Outstanding Performance” for four consecutive terms. In the 2018 Fortune Global 500 list, China Merchants Group made the list on its first application, setting a record for longevity among Chinese companies in the Fortune Global 500 with its 146-year history.

Huashan Hospital, Fudan University: Founded in 1907, it is a hospital directly affiliated with the National Health and Family Planning Commission, a teaching hospital affiliated with Fudan University, and a hospital named by the Red Cross Society of China. In 1992, it was among the first to pass the national review for Grade A tertiary hospitals. It is a National Civilized Unit and one of the most renowned medical, educational, and research centers in China with the most prominent international characteristics. It is also the first public hospital under a central ministry in China to obtain JCI accreditation, enjoying a high reputation both domestically and internationally.

Yizhan Medical Group: A high-tech enterprise that provides smart medical imaging solutions while focusing on the research, development, and application of artificial intelligence in medical imaging. Positioned in the market for computer-aided diagnosis, Yizhan Medical Group leverages cloud-based imaging diagnosis as its entry point to comprehensively deploy AI imaging R&D and applications. Its products have obtained CFDA, FDA, and CE certifications, successfully building a comprehensive medical imaging ecosystem centered on smart imaging services and delivering high-quality imaging diagnostics globally. The project has been inspected and affirmed by former Premier of the State Council Li Keqiang and former Vice Premier Sun Chunlan. Furthermore, Yizhan has participated in the formulation of multiple national standards in related fields.